Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
AP-1 mediates cellular adaptation and memory formation.
PMID 41862498 · PMC13168276 · Nature communications · 2026 · 8 claims · 7 setups
Cancer cells form and maintain cellular memories when becoming drug resistant, exhibiting cellular learning dependent on the transcription factor AP-1
-
Has reproduction · 40
5-HT reuptake blockade induces pyroptosis in BRAF(V600E)-mutated melanomas via remodeling histone serotonylation.
PMID 41494533 · PMC12866116 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
High-throughput screening of 90 FDA-approved antidepressants identifies PH as an alternative therapeutic for BRAF V600E-mutated melanoma
-
Full-text index only
Pre-existing cell states predict resistance to multiple treatments.
PMID 41916275 · PMC13261651 · Cell genomics · 2026 · 8 claims · 5 setups
Rare melanoma clones can develop resistance to multiple diverse treatments simultaneously, not just single treatments
-
Full-text index only
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.
PMID 19078957 · PMC2696133 · Nature · 2009 · 8 claims · 8 setups
GNAQ is frequently somatically mutated in blue nevi (83%) and uveal melanoma (46%)
-
Full-text index only
SPP1(+) macrophage-driven interactions shape the tumor microenvironment in lymph node metastatic acral melanoma.
PMID 42020397 · PMC13230793 · Cell death & disease · 2026 · 8 claims · 8 setups
LN+ acral melanoma shows preferential SPP1+ signaling, including autocrine amplification within SPP1+ macrophages and paracrine interaction with S100A8+ melanoma cells via the SPP1-CD44 axis
-
Has reproduction · 59
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
PMID 33086062 · PMC7649750 · Cell reports · 2020 · 8 claims · 8 setups
KMT2D is a potent tumor suppressor in melanoma
-
Full-text index only
Out-of-frame CBX3::ALK fusion drives ALK activation and therapy response.
PMID 41887222 · PMC13130619 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
A CBX3::ALK out-of-frame fusion was identified in a patient with metastatic melanoma